Latest Property News

Mayne Pharma has settled patent litigation with Sun Pharma over IMVEXXY, establishing 21 October 2032 as the agreed potential generic entry date, subject to court approval. The settlement involves no upfront payment, while one further Paragraph IV dispute remains unresolved.

Paradigm Biopharmaceuticals has entered voluntary administration after its pivotal Phase 3 trial produced an interim efficacy result below the threshold required for continuation. The company’s securities will remain suspended while administrators assess its viability, liabilities and possible restructuring options.

Silver Mines has built a substantially larger economic case for Bowdens, but the project still needs NSW approval before its 93.5 million ounce reserve can become a mine. The company is now funding the next phase with a A$70 million placement while absorbing dilution and a major royalty buy-back.

Metallium has moved Flash Joule Heating from tiny laboratory tests to multi-reactor campaigns in Texas, backed by feedstock contracts, offtake and A$125 million raised during FY2026. Yet the ASX-listed group remains pre-revenue, lost A$42.8 million and says continued access to funding is a material uncertainty.

Identitii’s BNDRY platform gained customers and recurring revenue in FY26, but the company ended the year with just $107,483 in cash, negative net assets and a material uncertainty over its ability to continue as a going concern. A subsequent convertible note facility provides a committed $5 million, while access to a further $15 million remains conditional.

Gullewa’s full-year profit fell sharply despite a $2.98 million royalty stream from the Deflector Project. The company is expanding its property and gold exposure while maintaining a fully franked dividend of 0.7 cents per share.

SkyCity has appointed UBS and Chapman Tripp to run a structured process exploring potential transactions and other ways to lift shareholder value, while continuing talks with two parties whose earlier approaches were rejected. The casino operator also expects major asset sale proceeds and says cost savings are tracking ahead of plan.

The Warehouse Group (NZX:WHS) returned to profit in FY26 and cut net debt by more than 80%, despite broadly flat comparable sales. The recovery came with a clear catch: The Warehouse brand remains loss-making and shareholders will receive no final dividend.

Group One Capital delivered a sharp revenue increase and remained profitable in FY2026 as structured finance emerged as a material new income stream. The opportunity is significant, but future fee receipts remain tied to project settlements, refinancing and contractual conditions.

RAM Essential Services Property Fund has posted a $30.1 million FY2026 statutory loss as property values weakened, while its planned $218.6 million retail sale prepares the fund for a healthcare-focused reset. The transaction could reduce gearing to 16.8%, but FY2027 distribution guidance is below the latest payout and refinancing remains unfinished.

TrivarX has made Stabl-Im its central development bet, but the ASX-listed health technology company also reported an $8.76 million FY2026 loss and an auditor-flagged material uncertainty over its ability to continue without further funding. The planned Phase 1 study remains subject to regulatory, ethics and operational clearances.

Australian Gold and Copper expanded its exploration footprint and advanced major targets during FY2026, but the campaign came with a larger loss and a sharp reduction in cash. The company now has a 38.5Moz silver-equivalent Achilles resource, a newly acquired Junee gold portfolio and further funding demands ahead.